Articles by Jeffrey C. Silva

About Jeffrey C. Silva
Jeffrey received his Ph.D. from Johns Hopkins University studying Natural Product Biosynthesis and completed his post-doc at Harvard Medical School investigating microbial signal transduction. After his post-doc, he worked for Microbia, Waters Corporation, and Cell Signaling Technology. Currently, he is Director of Product Development at Adeptrix Corporation producing new tools for multiplexed, targeted proteomics (https://www.linkedin.com/in/jeffreycruzsilva/).

A Multiplexed Microarray Platform (Affi-BAMS) for Targeted Proteomics by Adeptrix

May 29, 2020 Jeffrey C. Silva 0

“Affinity-Bead-Assisted Mass Spectrometry (Affi-BAMS) can simultaneously profile various proteins and applicable to all types of biological samples” By: Vladislav Bergo, Ph.D. CSO, Adeptrix Corp, Proteomic studies critically rely on multi-dimensional separation methods such as 2D-LC to simplify the complexity of enzymatically digested biological specimens before subsequent MS & MS/MS to efficiently [..]

Adeptrix Corporation Receives Funding from ICV Venture Engineering Fund I to Accelerate Product Development Pipeline and Advance Translational Research Biology

May 9, 2019 Jeffrey C. Silva 0

Adeptrix Corporation Receives Funding from ICV Venture Engineering Fund I to Accelerate Product Development Pipeline and Advance Translational Research Biology By: Jeffrey C. Silva, Ph. D. | Adeptrix Beverly, MA 01915, May 6th, 2019, Adeptrix Corporation announces the completion of initial investment through ICV Venture Engineering Fund I, for its [..]